Tyrosinaemia treatment now available as oral suspension

Prescribers have a new liquid formulation of nitisinone as an option for the treatment of children and adults with hereditary tyrosinaemia type 1.

Orfadin 4mg/ml suspension should be shaken vigorously immediately before a dose is withdrawn and administered. The liquid is administered via an oral syringe, three of which are included in each pack. Prescribers should advise patients how to administer the correct dose. 

Further information
View Orfadin Suspension drug record
Summary of Product Characteristics
Manufacturer: Sobi

As a result of increased tyrosine levels due to nitisinone's mode of action, patients may experience eye-related adverse effects such as conjunctivitis, corneal opacity, keratitis and photophobia.

Patients taking Orfadin should be on a tyrosine- and phenylalanine- restricted diet.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

MIMS launches Respiratory and Allergy Learning workshops 2019

MIMS launches Respiratory and Allergy Learning workshops 2019

Join us for the MIMS Workshops Respiratory and Allergy...

Hormone Replacement Therapy (HRT)

Hormone Replacement Therapy (HRT)

Hormone doses and costs of HRT preparations.

Widespread false diagnosis of COPD is exposing patients to unnecessary medication risks, study suggests
Blood Glucose Testing Strips and Meters

Blood Glucose Testing Strips and Meters

Compatible test strips for blood glucose meters.